Toward a Controlled Human Infection Model of Pertussis

Affiliations

¹ Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Comment

Tod J Merkel. Clin Infect Dis. 2020.

. 2020 Jul 11;71(2):412-414.

doi: 10.1093/cid/ciz842.

¹ Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

No abstract available

Keywords: Bordetella pertussis; human challenge; immunity; pathogenesis; vaccine.

Comment on

Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization.
de Graaf H, Ibrahim M, Hill AR, Gbesemete D, Vaughan AT, Gorringe A, Preston A, Buisman AM, Faust SN, Kester KE, Berbers GAM, Diavatopoulos DA, Read RC. de Graaf H, et al. Clin Infect Dis. 2020 Jul 11;71(2):403-411. doi: 10.1093/cid/ciz840. Clin Infect Dis. 2020. PMID: 31562530 Free PMC article. Clinical Trial.

1. Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev 2016; 29:449–86. - PMC - PubMed
1. Pinto MV, Merkel TJ. Pertussis disease and transmission and host responses: insights from the baboon model of pertussis. J Infect 2017; 74(Suppl 1):114–9. - PubMed
1. Chu HY, Englund JA. Maternal immunization. Clin Infect Dis 2014; 59:560–8. - PMC - PubMed
1. Klein NP. Licensed pertussis vaccines in the United States: history and current state. Hum Vaccin Immunother 2014; 10:2684–90. - PMC - PubMed
1. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650–60. - PubMed